Validation of patient-reported outcomes with the Migraine-Specific Quality of Life questionnaire

Takeaway

  • All three domains of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome (MSQ v2.1 ePRO) demonstrate sufficient validity, reliability, responsiveness and appropriate interpretation standards in patients with chronic (CM) or episodic migraine (EM).

Why this matters

  • The 14-item MSQ v2.1 ePRO comprises three domains: Role Function-Restrictive (RFR), Role Function-Preventive (RFP) and Emotional Function (EF), and has gradually gained clinical recognition, even being used in Phase 3 trials due to its focus on migraine-specific aspects.

  • Utilization of a reliable, accessible tool may reduce unnecessary travel to clinical settings for patients with migraine-induced disability burden; in addition, clinical services are increasingly moving to digital platforms, particularly in view of the COVID-19 pandemic.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.